Susquehanna International Group
NAVB

Susquehanna International Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Susquehanna International Group’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20,100
Closed -$20K – 14641
2021
Q4 		$20K Sell
20,100
-13,500
-40% -$19K ﹤0.01% 12835
2021
Q3 		$59K Sell
33,600
-48,200
-59% -$81.1K ﹤0.01% 12297
2021
Q2 		$150K Buy
81,800
+10,700
+15% +$18.9K ﹤0.01% 11860
2021
Q1 		$144K Buy
71,100
+6,000
+9% +$14K ﹤0.01% 11686
2020
Q4 		$140K Sell
65,100
-67,200
-51% -$158K ﹤0.01% 10294
2020
Q3 		$357K Buy
132,300
+90,700
+218% +$325K ﹤0.01% 8361
2020
Q2 		$164K Buy
41,600
+21,800
+110% +$41.7K ﹤0.01% 9200
2020
Q1 		$15K Sell
19,800
-24,100
-55% -$26.6K ﹤0.01% 9999
2019
Q4 		$55K Buy
43,900
+25,700
+141% +$22.2K ﹤0.01% 9327
2019
Q3 		$13K Buy
+18,200
New +$11.2K ﹤0.01% 9996
2016
Q2 		– Sell
-2,210
Closed -$42K – 9725
2016
Q1 		$42K Sell
2,210
-615
-22% -$11.8K ﹤0.01% 8702
2015
Q4 		$75K Buy
+2,825
New +$98.1K ﹤0.01% 8988
2015
Q3 		– Sell
-2,490
Closed -$81K – 10544
2015
Q2 		$81K Sell
2,490
-1,360
-35% -$39.5K ﹤0.01% 9748
2015
Q1 		$122K Buy
+3,850
New +$130K ﹤0.01% 8893
2014
Q1 		– Sell
-695
Closed -$29K – 9661
2013
Q4 		$29K Sell
695
-2,470
-78% -$96.7K ﹤0.01% 8873
2013
Q3 		$168K Buy
3,165
+2,080
+192% +$121K ﹤0.01% 7869
2013
Q2 		$58K Buy
+1,085
New +$54.2K ﹤0.01% 7947

Other funds holding NAVB

ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Susquehanna International Group's NAVB Position: Q3 2023 in Review

Susquehanna International Group sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q3 2023, closing a stake of 125,866 shares — an estimated $11.6K sold.

Susquehanna International Group first reported a position in NAVB in Q2 2013 and held it in 25 quarters. The position peaked at $14.2M in Q3 2015. 24 funds tracked by Wall St. Rank hold NAVB as of Q3 2023.

  • Susquehanna International Group reported no remaining Navidea Biopharmaceuticals Inc. position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 125,866 Navidea Biopharmaceuticals Inc. shares in Q3 2023, an estimated $11.6K.
  • Susquehanna International Group first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 25 quarters.
  • Susquehanna International Group's Navidea Biopharmaceuticals Inc. position peaked at $14.2M in Q3 2015.
  • 24 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.